MCID: HMP001
MIFTS: 41

Hemopericardium

Categories: Cardiovascular diseases

Aliases & Classifications for Hemopericardium

MalaCards integrated aliases for Hemopericardium:

Name: Hemopericardium 12 15 73
Pericardial Effusion 44 73
Haemopericardium 12

Classifications:



External Ids:

Disease Ontology 12 DOID:11482
ICD9CM 35 423.0
MeSH 44 D010490
NCIt 50 C111644
SNOMED-CT 68 155339006 23412002
ICD10 33 I31.2
UMLS 73 C0019064

Summaries for Hemopericardium

Disease Ontology : 12 A pericardial effusion that results from blood in the pericardial sac.

MalaCards based summary : Hemopericardium, also known as pericardial effusion, is related to cardiac tamponade and myocardial infarction. An important gene associated with Hemopericardium is KCNK6 (Potassium Two Pore Domain Channel Subfamily K Member 6), and among its related pathways/superpathways are Metformin Pathway, Pharmacodynamics and Sirolimus Pathway, Pharmacokinetics/Pharmacodynamics. The drugs Rivaroxaban and Colchicine have been mentioned in the context of this disorder. Affiliated tissues include lung, heart and kidney, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 76 Hemopericardium refers to blood in the pericardial sac of the heart. It is clinically similar to a... more...

Related Diseases for Hemopericardium

Diseases related to Hemopericardium via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 45)
# Related Disease Score Top Affiliating Genes
1 cardiac tamponade 10.4
2 myocardial infarction 10.3
3 pericarditis 10.3
4 aneurysm 10.2
5 constrictive pericarditis 10.2
6 cardiac rupture 10.1
7 acute myocardial infarction 10.0
8 endocarditis 9.9
9 angiosarcoma 9.8
10 infective endocarditis 9.8
11 ventricular septal defect 9.8
12 aortitis 9.8
13 hemophilia 9.8
14 aortic aneurysm, familial abdominal, 1 9.7
15 blue rubber bleb nevus 9.7
16 cardiac conduction defect 9.7
17 systemic lupus erythematosus 9.7
18 pectus excavatum 9.7
19 hemophilia b 9.7
20 leukemia, chronic myeloid 9.7
21 arteriovenous fistula 9.7
22 cerebral hemorrhage 9.7
23 leukemia 9.7
24 spinal cord injury 9.7
25 paraganglioma 9.7
26 atrial fibrillation 9.7
27 cardiac arrest 9.7
28 dressler's syndrome 9.7
29 sarcoma 9.7
30 heart disease 9.7
31 pericardial effusion 9.7
32 hypertrophic cardiomyopathy 9.7
33 essential thrombocythemia 9.7
34 coronary aneurysm 9.7
35 cerebritis 9.7
36 aortic aneurysm 9.7
37 seminoma 9.7
38 uremia 9.7
39 hyperthyroidism 9.7
40 mediastinitis 9.7
41 lupus erythematosus 9.7
42 evans' syndrome 9.7
43 pulmonary embolism 9.7
44 coronary artery aneurysm 9.7
45 rubeosis iridis 8.9 PLG RPTOR

Comorbidity relations with Hemopericardium via Phenotypic Disease Network (PDN):


Aortic Valve Disease 1 Familial Atrial Fibrillation
Heart Disease Intermediate Coronary Syndrome
Ischemic Heart Disease

Graphical network of the top 20 diseases related to Hemopericardium:



Diseases related to Hemopericardium

Symptoms & Phenotypes for Hemopericardium

GenomeRNAi Phenotypes related to Hemopericardium according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-100 9.61 SLC22A12
2 Increased shRNA abundance (Z-score > 2) GR00366-A-164 9.61 SLC22A12
3 Increased shRNA abundance (Z-score > 2) GR00366-A-185 9.61 CYP3A4
4 Increased shRNA abundance (Z-score > 2) GR00366-A-215 9.61 CYP3A4
5 Increased shRNA abundance (Z-score > 2) GR00366-A-35 9.61 CYP3A4 SLC22A12
6 Increased shRNA abundance (Z-score > 2) GR00366-A-57 9.61 CYP3A4
7 Increased shRNA abundance (Z-score > 2) GR00366-A-7 9.61 CYP3A4
8 Increased shRNA abundance (Z-score > 2) GR00366-A-90 9.61 SLC22A12
9 Upregulation of RLR pathway after Sendai virus (SeV) infection GR00302-A 8.62 KCNK6 PLG

Drugs & Therapeutics for Hemopericardium

Drugs for Hemopericardium (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 214)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Rivaroxaban Approved Phase 4,Phase 3,Phase 2 366789-02-8
2
Colchicine Approved Phase 4,Phase 3 64-86-8 6167 2833
3
Dalteparin Approved Phase 4,Phase 3 9005-49-6
4
Heparin Approved, Investigational Phase 4,Phase 3 9005-49-6 772 46507594
5
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
6
Everolimus Approved Phase 4 159351-69-6 6442177
7
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
8
Mycophenolate mofetil Approved, Investigational Phase 4 128794-94-5 5281078
9
Mycophenolic acid Approved Phase 4 24280-93-1 446541
10
Sirolimus Approved, Investigational Phase 4 53123-88-9 5284616 6436030 46835353
11
Amiodarone Approved, Investigational Phase 4,Not Applicable 1951-25-3 2157
12
Acetaminophen Approved Phase 4 103-90-2 1983
13
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
14
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
15
gamma-Aminobutyric acid Approved, Investigational Phase 4 56-12-2 119
16
Ibuprofen Approved Phase 4 15687-27-1 3672
17
Morphine Approved, Investigational Phase 4 57-27-2 5288826
18
Menthol Approved Phase 4,Not Applicable 2216-51-5 16666
19
Warfarin Approved Phase 4,Phase 2,Phase 3,Not Applicable 81-81-2 6691 54678486
20
Apixaban Approved Phase 4,Phase 3 503612-47-3 10182969
21
Serine Approved, Nutraceutical Phase 4,Phase 3,Phase 2 56-45-1 5951
22
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
23 Kava Approved, Investigational, Nutraceutical Phase 4,Not Applicable 9000-38-8
24 Anticoagulants Phase 4,Phase 2,Phase 3
25 Antithrombin III Phase 4,Phase 3,Phase 2
26 Antithrombins Phase 4,Phase 3,Phase 2
27 Factor Xa Inhibitors Phase 4,Phase 3,Phase 2
28 HIV Protease Inhibitors Phase 4,Phase 3,Phase 2
29
protease inhibitors Phase 4,Phase 3,Phase 2
30 Serine Proteinase Inhibitors Phase 4,Phase 3,Phase 2
31 Fibrinolytic Agents Phase 4,Phase 3,Phase 2,Not Applicable
32 Antirheumatic Agents Phase 4,Phase 3,Phase 2
33 Antimitotic Agents Phase 4,Phase 3,Phase 2,Phase 1
34 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
35 Immunosuppressive Agents Phase 4,Phase 2,Phase 3,Phase 1
36 calcium heparin Phase 4,Phase 3
37 Heparin, Low-Molecular-Weight Phase 4,Phase 3
38 Analgesics Phase 4,Phase 3,Phase 2
39 Analgesics, Non-Narcotic Phase 4,Phase 2
40 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2
41 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 2
42 Cyclooxygenase Inhibitors Phase 4,Phase 2
43 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Not Applicable
44 Anti-Bacterial Agents Phase 4,Phase 3,Phase 1,Phase 2
45 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 1,Phase 2
46 Antifungal Agents Phase 4
47 Antitubercular Agents Phase 4
48 Cyclosporins Phase 4
49 Anti-Arrhythmia Agents Phase 4,Phase 3,Not Applicable
50 Cytochrome P-450 CYP1A2 Inhibitors Phase 4,Not Applicable

Interventional clinical trials:

(show top 50) (show all 177)
# Name Status NCT ID Phase Drugs
1 The Effect of Chest Tubes Using Active Clearance Technology® on the Incidence of Postoperative Atrial Fibrillation Unknown status NCT02808897 Phase 4
2 SmartTouch Catheter for Left Anterior Line - SmarT Line Study Unknown status NCT02217657 Phase 4
3 Safety and Feasibility of Arrhythmia Ablation Using the Amigo Remote Robotic System as Compared With Manual Ablation Unknown status NCT01834872 Phase 4
4 Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban Unknown status NCT02549963 Phase 4 Rivaroxaban
5 Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer Completed NCT00942968 Phase 4 dalteparin
6 Non Steroidal Anti Inflammatory Treatment for Post Operative Pericardial Effusion Completed NCT00247052 Phase 4 diclofenac;diclofenac;matching placebo
7 Cochicine Treatment for Post- Operative Pericardial Effusion Completed NCT01266694 Phase 4 Colchicines;Placebo
8 Everolimus in de Novo Heart Transplant Recipients Completed NCT01017029 Phase 4 Everolimus;Mycophenolate mofetil + Everolimus
9 Prevention of Atrial Fibrillation Following Esophagectomy Completed NCT00420017 Phase 4 Amiodarone
10 Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter Completed NCT00318565 Phase 4
11 Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults Completed NCT00744263 Phase 4
12 Multimodal Analgesic Treatment Versus Traditional Morphine Analgesia After Cardiac Surgery Completed NCT01966172 Phase 4 Ibuprofen;Gabapentin;Morphine;Paracetamol
13 Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension Completed NCT01642407 Phase 4 Sildenafil
14 Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion Recruiting NCT02260206 Phase 4 Colchicine
15 Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation Recruiting NCT02426944 Phase 4 NOAC
16 Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER) Recruiting NCT02339974 Phase 4
17 NAVISTAR® THERMOCOOL® Catheter Post Approval Registry Active, not recruiting NCT00964392 Phase 4
18 Dabigatran in Patients With Atrial Fibrillation and Mitral Biological Prostheses Enrolling by invitation NCT03183843 Phase 4 Dabigatran Etexilate;Warfarin
19 Anticoagulation in AF Ablation and Effects on Neurocognitive Function Withdrawn NCT02120560 Phase 4
20 Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension Withdrawn NCT02893995 Phase 4 Slow Dose Titration Group of Subcutaneous Treprostinil;Rapid Dose Titration Group of Subcutaneous Treprostinil
21 COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial) Unknown status NCT01552187 Phase 3 Colchicine;Placebo
22 ELIGIBLE (Efficacy of Left atrIal Appendage Closure After GastroIntestinal BLEeding) Unknown status NCT01628068 Phase 3
23 Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion Completed NCT00132613 Phase 3 Pericardial instillation of bleomycin after drainage
24 A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis Completed NCT00810849 Phase 3 Prednisolone
25 WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation Completed NCT00129545 Phase 2, Phase 3 Warfarin
26 THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation Completed NCT01385202 Phase 3
27 NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation Completed NCT00116428 Phase 3 Antiarrhythmic drug
28 THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS Completed NCT01639495 Phase 3
29 Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events Completed NCT01675076 Phase 3 Dabigatran;Rivaroxaban;Apixaban
30 Scleroderma: Cyclophosphamide or Transplantation (SCOT) Completed NCT00114530 Phase 2, Phase 3 cyclophosphamide
31 Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer Completed NCT00347412 Phase 3 Paclitaxel and Carboplatin;NOV-002 Injection in combination with Carboplatin vs. Paclitaxel and Carboplatin
32 A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse) Completed NCT00046228 Phase 3 abciximab placebo; reteplase placebo, abciximab, abciximab;Abciximab; reteplase; abciximab placebo; abciximab;abciximab; reteplase placebo; abciximab placebo; abciximab;abciximab placebo; reteplase placebo, abciximab, abciximab;abciximab; reteplase placebo; abciximab placebo; abciximab;Abciximab; reteplase; abciximab placebo; abciximab
33 Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer Completed NCT00744497 Phase 3 Placebo;Dasatinib;Docetaxel;Prednisone
34 An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy Completed NCT00791492 Phase 2, Phase 3 Fx-1006A
35 IMPI 2 - A Trial of Intrapericardial Alteplase in Large Pericardial Effusion Recruiting NCT02673879 Phase 3
36 WAVECREST Post Market Clinical Follow-Up (PMCF) Study Recruiting NCT03204695 Phase 3
37 Dasatinib Holiday for Improved Tolerability Recruiting NCT02890784 Phase 3 dasatinib (SPRYCEL®)
38 International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia Recruiting NCT02724163 Phase 3 Gemtuzumab ozogamicin;Liposomal daunorubicin;Mitoxantrone;Fludarabine;Cytarabine;Busulfan;Cyclophosphamide
39 Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban Active, not recruiting NCT02746185 Phase 3 rivaroxaban;Low-molecular-weight heparin
40 Colchicine in Postoperative Fontan Patients Not yet recruiting NCT03575572 Phase 2, Phase 3 Colchicine
41 NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study Terminated NCT00721149 Phase 3
42 NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer Unknown status NCT00994097 Phase 2 NGR-hTNF;Cisplatin;Gemcitabine;Pemetrexed
43 Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population Unknown status NCT02493075 Phase 1, Phase 2
44 ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment Unknown status NCT00005645 Phase 2 ILX-295501
45 Combined CABG and Stem-Cell Transplantation for Heart Failure Unknown status NCT00418418 Phase 2
46 Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty Completed NCT02271399 Phase 2 acetylsalicylic acid;rivaroxaban
47 Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC) Completed NCT00431015 Phase 1, Phase 2 IPI-504
48 Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Completed NCT00850382 Phase 1, Phase 2 Dasatinib;daunorubicin;Cytarabine
49 A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) Completed NCT00318136 Phase 2 Bevacizumab;Carboplatin;Paclitaxel
50 Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC) Completed NCT00942825 Phase 2 CBP501 + Cisplatin + Pemetrexed;Cisplatin + Pemetrexed

Search NIH Clinical Center for Hemopericardium

Cochrane evidence based reviews: pericardial effusion

Genetic Tests for Hemopericardium

Anatomical Context for Hemopericardium

MalaCards organs/tissues related to Hemopericardium:

41
Lung, Heart, Kidney, Endothelial, Prostate, Myeloid, Breast

Publications for Hemopericardium

Articles related to Hemopericardium:

(show top 50) (show all 980)
# Title Authors Year
1
Incidence of pericardial effusion after left atrial appendage closure: The impact of underlying heart rhythm-Data from the EWOLUTION study. ( 29722469 )
2018
2
Possible involvement of IL-6-producing tissue-resident macrophages in early-onset pericardial effusion pathogenesis after hematopoietic stem cell transplantation. ( 29384263 )
2018
3
A Case Series of Two Patients Presenting With Pericardial Effusion as First Manifestation of Non-Small Cell Lung Cancer With <i>BRAF</i> Mutation and Expression Of PD-L1. ( 29760834 )
2018
4
Reply to the letter: &amp;quot;Pericardial effusion in community-acquired pneumonia: casuality or etiology?&amp;quot; ( 29735269 )
2018
5
Pericardial effusion following cardiac surgery. A single-center experience. ( 29171276 )
2018
6
Massive pleural and pericardial effusion due to hypothyroidism in a patient with a surgically treated thyroid-stimulating hormone-producing pituitary adenoma. ( 29757110 )
2018
7
Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature. ( 29761026 )
2018
8
Relevant pericardial effusion caused by cytomegalovirus infection in an immunocompetent patient: a case report. ( 29347961 )
2018
9
Pericardial Effusion in Obstructive Sleep Apnea without Pulmonary Arterial Hypertension and Daily Hypoxemia - is it Unusual? ( 29808980 )
2018
10
Idiopathic Loculated and Septated Pericardial Effusion. ( 29871831 )
2018
11
Recurrent Pericardial Effusion While Receiving Nivolumab for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature. ( 29937384 )
2018
12
Pleural and pericardial effusion in a long-term PD patient - a defying diagnosisa8c. ( 29231161 )
2018
13
Morphology quiz: Pericardial effusion as first manifestation of malignancy. ( 29732625 )
2018
14
A Rare Case of Hemopericardium From a Ruptured Dissecting Pulmonary Artery Aneurysm: Postmortem Computed Tomography Scan and Autopsy Findings. ( 29120872 )
2018
15
Idiosyncratic Pericardial Effusion Associated With Minoxidil. ( 29746289 )
2018
16
Hemopericardium After TAVR: Assessment. ( 29706568 )
2018
17
Left Atrial Appendage Perforation Does Not Always Mean Pericardial Effusion. ( 29880108 )
2018
18
PCR evaluation of selected vector-borne pathogens in dogs with pericardial effusion. ( 29355984 )
2018
19
Systemic sclerosis: severe pulmonary arterial hypertension and pericardial effusion at diagnosis. ( 29764826 )
2018
20
Massive pericardial effusion without cardiac tamponade due to subclinical hypothyroidism (Hashimoto's disease). ( 29778090 )
2018
21
Treatable massive pericardial effusion and hypertrophic cardiomyopathy in an infant with a novel homozygous ACADVL mutation: A case report. ( 29768383 )
2018
22
Pericardial effusion unrelated to surgery is a predictor of mortality in heart transplant patients. ( 29341061 )
2018
23
Atypical Presentation of a Large Pericardial Effusion after Heart Transplantation in a Patient with Dilated Cardiomyopathy. ( 29429930 )
2018
24
Pericardial effusion as an atypical initial presentation of extra-gonadal nonseminomatous germ cell tumor: a case report and literature review. ( 29492268 )
2018
25
Cough as the sole manifestation of pericardial effusion. ( 29437733 )
2018
26
Massive Hemorrhagic Pericardial Effusion With Cardiac Tamponade as Initial Manifestation of Mixed Connective Tissue Disease. ( 29479391 )
2018
27
Non-small cell lung carcinoma metastatic cells in a pericardial effusion. ( 29714042 )
2018
28
Large pericardial effusion and tamponade in young male with Niemann-Pick disease type C. ( 29898264 )
2018
29
Pericardial effusion in community-acquired pneumonia: Casuality or etiology? ( 29859646 )
2018
30
A rare cause of pericardial effusion due to intracardiac cement embolism. ( 29718318 )
2018
31
Non-operative management is feasible for selected blunt trauma patients with pericardial effusion. ( 29191668 )
2018
32
Non-surgical management in hemodynamically unstable blunt traumatic pericardial effusion: A feasible option for treatment. ( 29980487 )
2018
33
The Intra-Pericardial Paraganglioma Presenting as Ascites and Hemopericardium with Impending Tamponade. ( 29681569 )
2018
34
Safety-pin Induced Hemopericardium and Cardiac Tamponade in an Infant. ( 29978823 )
2018
35
First reported case series in the United States of hemopericardium in patients on apixaban. ( 29876295 )
2018
36
Acute Decompensation after Hemodialysis in a Patient with Pericardial Effusion. ( 29714100 )
2018
37
The Echocardiographic Characteristics and Prognostic Significance of Pericardial Effusions in Eisenmenger Syndrome. ( 28882496 )
2017
38
Large Pericardial Mass Mimicking Pericardial Effusion. ( 29184620 )
2017
39
Diagnosis of systemic inflammatory diseases among patients admitted for acute pericarditis with pericardial effusion. ( 28937580 )
2017
40
Chondrosarcoma: Extrinsic Compression of the Right Ventricle and Pericardial Effusion. ( 28709860 )
2017
41
Case of generalized pustular psoriasis presenting with both pleural effusion and pericardial effusion collection. ( 28636215 )
2017
42
Drug-Induced by Systemic Lupus Erythematosus Presenting as Recurrent Pericardial Effusion After Mitral Valve Repair. ( 29202555 )
2017
43
Infantile Systemic Hyalinosis Complicated with Right Atrial Thrombus and Pericardial Effusion in an Infant. ( 25458638 )
2017
44
An unusual case of sudden unexpected death due to massive hemopericardium from primary mediastinal seminoma. ( 28341006 )
2017
45
Factors Affecting Survival in Children With Pericardial Effusion After Hematopoietic Stem Cell Transplantation. ( 29338379 )
2017
46
Pericardial Effusion: A Rare Side Effect of TNF-Alpha Blocking Agent. ( 28742729 )
2017
47
Tacrolimus as a Rare Cause of Pericardial Effusion in a Renal Transplant Recipient. ( 29326779 )
2017
48
Ethanol injection into the Marshall vein provoking a pericardial effusion resulting in a fatal complication in a patient with persistent atrial fibrillation. ( 28878915 )
2017
49
ANA-Negative Hydralazine-Induced Pericardial Effusion. ( 29391867 )
2017
50
Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end-stage renal disease: Insights and pathophysiology. ( 28873222 )
2017

Variations for Hemopericardium

Expression for Hemopericardium

Search GEO for disease gene expression data for Hemopericardium.

Pathways for Hemopericardium

Pathways related to Hemopericardium according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.51 CYP3A4 RPTOR
2 9.8 CYP3A4 RPTOR

GO Terms for Hemopericardium

Sources for Hemopericardium

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....